SBHMY

PINK Sino Biopharmaceutical Limited Unsponsored ADR

Nov 6, 2026 · 4:23 AM ET EOD Market Closed

$14.17 ↑ +0.00 (+0.00%) Trading Up from the previous close of $14.17, and at the day’s high of $14.17

YTD change: +2.27%
vs 20-day SMA: +2.67%
vs 200-day SMA: N/A

Price ranges

Previous day

$14.12 $14.17

open $14.12 close $14.17

+$0.05 (+0.38%)

Today

$14.12 $14.17

$14.17

Past week

$12.04 $13.82

from $12.67 now $14.17

+$1.50 (+11.87%)

Past month

$12.04 $16.28

from $14.38 now $14.17

-$0.21 (-1.43%)

This year

$11.27 $17.65

from $13.86 now $14.17

+$0.31 (+2.27%)

Price & Performance

+1.69 (+13.53%) / 6M

Signals & Sentiment

Momentum, market sentiment, and recent alerts

N/A

The stock is 22.2% away from all-time highs of $18.22
SBHMY is up 2% since the beginning of the year
SBHMY is up 2% over the past 12 months
SBHMY is down 1% over the past 1 month

SBHMY reads n/a: the 12-month move is -22.2%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable N/A

EPS N/A

Earnings momentum N/A Quarterly EPS growth

Quarterly change N/A

Valuation

P/E ratio N/A

Enterprise value $12.3B

Beta 0.50

Balance sheet & scale

Income$359.3K

Revenue$4.8B

Cash$4.1B

Debt$2.5M

Income / Debt 0.14×

Company & Peers

Company profile and competitor comparison

Company profile

ExchangePINK

Sector Manufacturing

Sub Sector Chemical Manufacturing

Market cap $12.6B

Sino Biopharmaceutical Ltd. is an investment holding company, which engages in the manufacture and sale of pharmaceutical products. It operates through the following business segments: Investment, Modernised Chinese Medicines and Chemical Medicines; and Others. The Investment segment offers long-term investments. The Modernised Chinese Medicines and Chemical Medicines segment comprises the manufacturing, selling, and distribution of modernized Chinese medicine products and western medicine products. The Investment segment offers long-term investments. The Other segment includes a research and development sector, which provides services to third parties; and related healthcare and hospital business. It also develops medicines for treating tumors, analgesia, diabetes, and respiratory system diseases. The company was founded by Ping Tse Cheung Ling Cheng and on February 2, 2000, and is headquartered in Hong Kong.

Competitor comparison

Ticker	Company	Price	Change
LLY	Eli Lilly and Company	$1,364.73	-3.76%
JNJ	Johnson & Johnson	$272.32	-1.45%
ABBV	AbbVie, Inc.	$288.24	-2.24%
MRK	Merck & Co., Inc.	$146.94	-2.27%
RHHBY	Roche Holding Ltd Sponsored ADR	$59.45	-2.45%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.